Connect with us

Featured

Stock Price Update: Premier Health Group (OTC: PHGRF) (CSE: PHGI) Seizing Opportunity; Rapid Growth Ahead?

Joe Samuel

Published

on

In the stock market, investors have been cautious following the massive volatility we’ve seen this quarter.  This can make it very difficult to navigate the waters of the stock market. But like we said just a few weeks ago, you need to be able to connect the right dots to find real opportunity.

This month StockPrice has brought a new company to everyone’s attention: Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI). We’ve put together a full report together that highlights how Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could have the same “early potential” as some of the biggest breakouts the small-cap space has seen this year.

There’s a VERY GOOD REASON to pay attention right now:

While everyone is still trying to figure out the “latest trend” in the stock market, big funds are quietly doing something that isn’t getting mass media coverage right now.


Funds Are Redirecting Cash Into Healthcare Stocks


What are they doing? Well, it just so happens that this month Bank of America surveyed[1] 225 fund managers with $641 billion in assets under management, who said the most “crowded trade” is in mainstream tech stocks. Investors are the least optimistic on mainstream tech stocks since the depths of the financial crisis and are instead directing attention to another corner of the market: healthcare.

The survey found that global investors rate health stocks their No. 1 overweight. And in November, they have been selling tech stocks to pile into stock in this sector. As investors make a push to grab hold of the expanding healthcare opportunity, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could be perfect timing this new trend that the majority of funds, like the ones surveyed, are paying close attention to right now.


Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) Takes Aim At Big Growth


On October 31 we published the article, “Ever Hear Of Connecting The Dots? Consider This Your Heads Up.” We wanted to make sure everyone understood the opportunities that this small cap market is presenting right now and emphasize the fact that you don’t need to be Apple Inc. or Amazon to deliver real gains to investors.

Thus far Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has begun to see much more market activity this month. This company is brand new to the North American public markets & with the series of recent announcements, Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could be slated for a strong period of growth in the very near term.

This quarter Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced their selection of Reliq Health Technologies Inc. as its exclusive technology partner. Reliq is “a healthcare technology company that specializes in developing innovative software as a service solution for the $30 billion community care market.”

Premier Health (OTC: PHGRF) (CSE: PHGI) will look to Reliq to further HealthVue’s telemedicine system by incorporating their technology platform to power the HealthVue patient app.


Latest News Could Open HUGE Doors ForPremier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)


If you haven’t been paying close attention to our updates, consider this your opportunity to get caught up because the company has been strongly focused on growth. Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) announced two key updates that could bring that “very near term potential” directly into the spotlight.

marijuana pharmacy

First, Premier announced that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019. Following this, Premier announced that it will enter the Cannabis clinic space by a series of acquisitions, partnerships and/or launching a new Canada-based chain in the first half of 2019.

Before we get too far into it…we’re less than two months away from 2019 and Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is flat out saying that they will be looking to engage with 2 multibillion-dollar industries within the first half of 2019.

We talk about connecting the dots. Showing you how timing could play a role is just one piece of the pie. Let’s also consider what the marketplace in Canada could offer specifically to Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI).

1. The Canadian retail pharmacy market is estimated to be $44 billion (Source: IBISWorld). It is expected the industry sector will continue to allow for favorable economics for pharmacy operators as baby boomer’s demand increases for prescriptions and operators to expand the scope of practice to include preventative services.

2. The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025.

If these two facts weren’t enough, there is also a MAJOR Cross Over in Canada that connects medical cannabis & retail pharmacies. For some reason, news outlets aren’t paying attention to it right now either.

The crossover: Canadian pharmacies are fully behind medical marijuana too! Shoppers, Lovell Drugs and PharmaChoice have all signed supply deals with leading cannabis producers in Canada. Their pending entry into the medical cannabis market comes as the number of registered MMJ patients is soaring.

Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) could have an ideal business model in progress that would vertically integrate cannabis as another growth opportunity; it could be only months away as the company states the plan being for the first half of 2019.


This Could Be Just The Beginning


Why say this? Statistics from Premier Health’s subsidiary, HealthVue, show that roughly 15% of Canadians aged 12 and older don’t have a primary care physician. On top of this, nearly two-thirds of seniors are also unable to get a same-or next-day appointment. This contributes to about 7 in 10 Canadians avoiding seeing a doctor when they are sick.

Though cannabis is very exciting, it represents just one part of what could become an even larger market opportunity for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI). HealthVue has an ecosystem of over 100,000 active patients, and according to the company, they also have plans to “rapidly increase that number both domestically and internationally.” Unlike other telehealth companies, HealthVue also has four clinics in British Columbia with plans to expand to the rest of Canada via its telemedicine model.

The benefit for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) is that it can tap into the existing payment structure that Canada offers. Unlike the US, the telemedicine visits are already covered by the provincial health insurance plans in several provinces, so there is no cost to the patient to access this service. HealthVue expects to make the first version of the app available to their patients in Q4-18.

health care technology

Besides cannabis, big pharmacies and healthcare systems are beginning to see the light when it comes to telemedicine. The resulting success could open big doors for the global market and for companies like Premier Health (OTC: PHGRF) (CSE: PHGI) to get a piece of the pie. Just look at some of the leading pharmacies aiming telemedicine:

1. Rite Aid (RAD), the third largest pharmacy in America, has begun searching for a useful telehealth technology for its customers both in store and virtually.

2. Walgreens (WBA) is connecting with more than a dozen healthcare providers, working to launch a new virtual marketplace used to join its online customers with store- and community-based services.

3. CVS has even begun to explore opportunities in telehealth with early ventures. The CVS Pharmacy app leverages back-end technology of telemedicine to offer the service to its subscribers.

The “Big Three” in the pharmacy industry are looking for the advantage and telemedicine could give them just that. The move follows the trends of a new consumer and the tendency to shift care outside of hospitals and clinics to where patients already are. Could Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) be next to get a nod for its telehealth platform?


Market Opportunity Indicates Rapid Growth


Telemedicine is also becoming a more significant part of health care treatment in rural areas, and more hospitals are embracing video consultations.  Reports[2] from firms like Polaris Market Research & Consulting found that the global telehealth market was valued at $3.1 Billion in 2017 and is anticipated to reach $16.7 Billion by 2025 growing at a CAGR of 23.5%.

After observing this kind of rapid expansion within a short period, it stands to reason that not only is healthcare in for a change but also calls for more attention to be placed on companies getting involved early on.

The opportunity to see rapid market adoption in Canada could offer companies within this industry an even greater opportunity. With the healthcare arena, especially in Canda, presenting numerous opportunities for growth Premier Health Group (OTC: PHGRF) (CSE: PHGI) could have a first mover advantage and the upper hand.

Click Here For Full Report On Premier Health Group (OTC: PHGRF) (CSE: PHGI)

stock price

Endnotes:

[1] Bank of America Survey: http://rsch.baml.com/r?q=ui5Blsf2sZL82JuY5OSH6g&e=cburroughs%40businessinsider.com&h=0tU5cQ&ps=true

[2] Polaris Market Research: https://www.polarismarketresearch.com/press-releases/telehealth-market/

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full disclaimer.

Continue Reading
Click to comment

Featured

Biotechnology Could Cure It All

Daniel Chase

Published

on

stock_price_biotech

Nearly two-thousand years ago, give or take several minutes, Hippocrates taught that human existence was centered around the four elements — earth, water, fire, and air — which in the human body was represented by the four basic humors: blood, phlegm, black bile, yellow bile. Hippocrates explained that each humor was located in a specific organ of the human body and each related to its own personality type — sanguine, phlegmatic, melancholic, and choleric.

‘Therefore, if someone was sick, Hippocrates taught that this indicated an imbalance in one of the four humors, so treatment included removing a given amount of the imbalanced humor through purging, bloodletting, etc. For those unfamiliar with bloodletting, it is the removal of some a patient’s blood which, in modern times, seems completely feasible, but back then this involved draining blood out of a person. 

Suffice to say that the medical field has moved forward since 460 BC, and recently, these advancements have occurred in the biotechnology industry. Though biotech is a relatively new field, it possesses great potential for the future of medicine. One of the more recent breakthroughs in biotech stems from something called pharmacogenomics, or the study of how genetics affect a person’s response to drugs. This new field combines the science of developing drug treatments and research conducted on human genetics and their functions. 

Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond

According to the U.S. National Library of Medicine, most drugs currently available on the market are branded as “one size fits all,”meaning that this specific treatment was created to cure a certain ailment for anyone who takes it. However, as scientists in the pharmacogenomics field are discovering, not everyone reacts the same to certain drugs.

For example, if two individuals are having an allergic reaction and both ingest an anti-histamine, it’s possible that it will help one person feel better, while causing adverse side-effects to the other person. By studying a person’s genetic coding, medical experts are better able to predict how a medication will effect a particular person. 

Ironically enough, as new technologies and inventive approaches to curing diseases come to light, medical researchers are discovering new diseases that seek to test all the progress we’ve made thus far. The practices of medicine have taken massive strides over the past few generations through the pioneering of biotechnology research and other incredible advancements, but regardless of these steps forward, it is up to companies in the healthcare industry to responsibly tend to the needs of their patients. 

Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) is a Canadian publicly traded company strategically poised to take advantage of lucrative business opportunities in the global healthcare industry. The Company is working to develop innovative healthcare approaches that combine human skill-based expertise with emerging technologies. What sets the Company apart from others in the field is that Premier is focused on developing their healthcare platform with a patient centric focus, looking to restore power back to the patients. For far too long, patients have been at the mercy of pharmaceutical companies who, by virtue of their capital, have maintained a chokehold on the price of drugs that patients need to stay healthy. 

In addition to rising treatments costs, as the global population increases, there are less primary physicians available for consumers looking to be cured. Through the use of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) HealthVue app, patient can see their physician, access their charts & lab results, chat securely with clinical staff, reorder prescriptions and share remote health monitoring data with their doctor – all at their fingertips. The HealthVue app utilizes a virtual care platform designed to be easy to use and to improve a patient’s access to primary care. 

In addition these advanced healthcare solutions, the Company shared, in their most recent corporate update, that they plan on utilizing artificial intelligence to assist in virtually triaging the needs of their patients. Using their Healthvue app, the patient will answer a series of questions which will be relayed to the physician, along with a differential on possible diagnoses. This information will be pre-populated to the physicians charting system and will provide key patient information prior to the scheduled virtual visit, saving them a considerable amount of time and allowing more time for patient interaction. 

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Continue Reading

Featured

Stock Price Newsletter – February 21, 2019

Joe Samuel

Published

on

stock price newsletter

One Stock To Watch Ahead Of Healthcare Boom

See For Yourself


The Future Is Delicious

Details Here


Here’s What You Missed 2/20/19

Get The Full Story Here


Continue Reading

Featured

Mueller Investigation Is Almost Ready

Daniel Chase

Published

on

stock_price_mueller

A half-witted, know-nothing playwright by the name of William Shakespeare once wrote that “these violent delights have violent ends.” The line, taken from Shakespeare’s Romeo and Juliet, also featured in Westworld, depicts a scene in which Friar Laurence cautions Romeo into falling for Juliet because his love may catalyze his own violent end. I attribute the words of Shakespeare to the current predicament facing President Donald Trump and his administration. In the two or so years since Trump took office, special counsel Robert Mueller has worked without end to investigate whether the Trump administration colluded in any way, shape, or form, with Russia during the 2016 presidential election. 

After countless subpoenas and inducements of former Trump associates and administration members, sources indicate that Mueller’s long nights away from the family could soon be over. Towards that end of January, Roger Stone, a former associate of Donald Trump before he became president, was indicted on charges of seeking stolen emails from WikiLeaks that could damage Trump’s opponents during the 2016 presidential election season. 

Per the official language of the indictment:

“…After the 2016 U.S. presidential election, the U.S. House of Representatives Permanent Select Committee on Intelligence, the U.S. Senate Select Committee on Intelligence, and the Federal Bureau of Investigation opened or announced their respective investigations into Russian interference in the 20126 U.S. presidential election…Stone took steps to obstruct these investigations….He made false statements to the HPSCI about his interactions regarding WikiLeaks, and falsely denied possessing records that contained evidence…”

-Robert Stone indictment 

The indictment went on to explain that Stone attempted to persuade a witness to provide false testimony and withheld pertinent information from federal investigators. According to several sources, Stone was arrested by the FBI Friday morning while drinking his morning coffee at his home in Florida. Stone’s attorney immediately attempted to defuse any public sentiment stirring up connecting Stone to special counsel Mueller’s investigation, suggesting that Stone’s indictment “focuses on allegedly false statements…made to Congress,” and has nothing to do with Russian collusion. 

According to CNN, Attorney General Bill Barr is limbering up in preparation to announce as early as next week the completion of Robert Mueller’s investigation, “with plans for Barr to submit to Congress soon after a summary” of the confidential report is prepared. Interestingly enough, though the details of the report concern both the American people and its presiding government, under special counsel regulations, Mueller must submit his “report” to the attorney general and the law doesn’t require this document to be shared with anyone.

Barr is under no formal obligation to publicly share the report, but I can already assume that members of the Democratic leadership will be banging on his office door until he throws them a bone. 

The question on everyone’s mind is, what Mueller discovered in his lengthy investigation. Mueller was appointed to the case on May 17, 2017, and in years following this date, Mueller has had his hands full. Early last week, Mueller’s office filed its sentencing memorandum against Paul Manafort, Trump’s former campaign manager, who will be sentenced next month in federal district court in the District of Columbia. 

“For a decade, Manafort repeatedly violated the law. Considering only the crimes charged in this district, they make plain that Manafort chose to engage in a sophisticated scheme to hide millions of dollars from United States authorities. The sentence in this case must take into account the gravity of this conduct, and serve to both specifically deter Manafort and those who would commit a similar series of crimes.”

sentencing memo from Robert Mueller

As for the findings of Mueller’s investigation, we will have to wait and see how Attorney General Barr chooses to go about sharing the report, if he ends up sharing the information at all. The information could disturb the Trump presidency and possibly give Democrats grounds for introducing articles of impeachment. 

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com